Concepedia

Publication | Open Access

The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma

70

Citations

45

References

2017

Year

References

YearCitations

Page 1